Last 12 months
Inside the activity.
3 purchase rows · 12 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 4 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 1 | 0 |
| Jun 2026 | 2 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 13, 2022 Filed Sep 15, 2022 20:24 UTC |
COLLIS STEVEN HDirector · Chairman, President & CEO
|
SaleCommon Stock | 11,480 | $142.40 | $1,634,752.00 |
DisclosureSEC source: 0001140859-22-000052 · wf-form4_166327348294030.xml · nonDerivative · entry 2 COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 205,178 F1 · shares: The sale of stock reflected in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person effective 8/20/21 and disclosed in the Company's 8-K filed with the Security and Exchange Commission on 8/26/21. Read SEC document |
| September 13, 2022 Filed Sep 15, 2022 20:24 UTC |
COLLIS STEVEN HDirector · Chairman, President & CEO
|
Exercise / conversionCommon Stock | 11,480 | $75.61 | $868,002.80 |
DisclosureSEC source: 0001140859-22-000052 · wf-form4_166327348294030.xml · nonDerivative · entry 1 COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 216,658 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale of stock reflected in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person effective 8/20/21 and disclosed in the Company's 8-K filed with the Security and Exchange Commission on 8/26/21. Read SEC document |
| September 02, 2022 Filed Sep 6, 2022 20:48 UTC |
Donato Leslie EEVP & Chief Strategy Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 2,975 | $0.00 | $0.00 |
DisclosureSEC source: 0001140859-22-000050 · wf-form4_166249730581647.xml · derivative · entry 3 Donato Leslie E · CIK 0001784795 · EVP & Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,975 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Grant of restricted stock units received for no consideration and vests 100% on the third anniversary of the date of grant. F1 · derivative.exercise_date: Grant of restricted stock units received for no consideration and vests 100% on the third anniversary of the date of grant. F1 · derivative.expiration_date: Grant of restricted stock units received for no consideration and vests 100% on the third anniversary of the date of grant. Read SEC document |
| September 02, 2022 Filed Sep 6, 2022 20:48 UTC |
Donato Leslie EEVP & Chief Strategy Officer
|
Tax withholdingCommon Stock | 1,108 | $147.71 | $163,662.68 |
DisclosureSEC source: 0001140859-22-000050 · wf-form4_166249730581647.xml · nonDerivative · entry 2 Donato Leslie E · CIK 0001784795 · EVP & Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,675.967 Read SEC document |
| September 02, 2022 Filed Sep 6, 2022 20:48 UTC |
Donato Leslie EEVP & Chief Strategy Officer
|
Exercise / conversionCommon Stock | 2,975 | $0.00 | $0.00 |
DisclosureSEC source: 0001140859-22-000050 · wf-form4_166249730581647.xml · nonDerivative · entry 1 Donato Leslie E · CIK 0001784795 · EVP & Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,783.967 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Grant of restricted stock units received for no consideration and vests 100% on the third anniversary of the date of grant. Read SEC document |
| August 30, 2022 Filed Sep 1, 2022 20:05 UTC |
Clark GinaExecutive Vice President
|
SaleCommon Stock | 288 | $146.80 | $42,278.40 |
DisclosureSEC source: 0001140859-22-000047 · wf-form4_166206274353504.xml · nonDerivative · entry 1 Clark Gina · CIK 0001625811 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,526 Read SEC document |
| August 09, 2022 Filed Aug 11, 2022 20:14 UTC |
COLLIS STEVEN HDirector · Chairman, President & CEO
|
Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 11,480 | $0.00 Strike: $75.61 | $0.00 |
DisclosureSEC source: 0001140859-22-000045 · wf-form4_166024883741172.xml · derivative · entry 3 COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,880 Underlying: Common Stock · 11,480 shares Expires 2023-11-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Exercisable in four equal annual installments on 11/9/17, 11/9/18, 11/9/19 and 11/9/20. Read SEC document |
| August 09, 2022 Filed Aug 11, 2022 20:14 UTC |
COLLIS STEVEN HDirector · Chairman, President & CEO
|
SaleCommon Stock | 11,480 | $144.25 | $1,655,990.00 |
DisclosureSEC source: 0001140859-22-000045 · wf-form4_166024883741172.xml · nonDerivative · entry 2 COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 205,178 F1 · shares: The sale of stock reflected in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person effective 8/20/21 and disclosed in the Company's 8-K filed with the Security and Exchange Commission on 8/26/21. Read SEC document |
| August 09, 2022 Filed Aug 11, 2022 20:14 UTC |
COLLIS STEVEN HDirector · Chairman, President & CEO
|
Exercise / conversionCommon Stock | 11,480 | $75.61 | $868,002.80 |
DisclosureSEC source: 0001140859-22-000045 · wf-form4_166024883741172.xml · nonDerivative · entry 1 COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 216,658 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale of stock reflected in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person effective 8/20/21 and disclosed in the Company's 8-K filed with the Security and Exchange Commission on 8/26/21. Read SEC document |
| August 01, 2022 Filed Aug 3, 2022 20:02 UTC |
NALLY DENNIS MDirector
|
GrantCommon Stock | 215 | $145.93 | $31,374.95 |
DisclosureSEC source: 0001140859-22-000043 · wf-form4_165955690726132.xml · nonDerivative · entry 1 NALLY DENNIS M · CIK 0001685596 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,199 F1 · shares: Shares of common stock were issued in lieu of $31,250 quarterly cash retainer. Read SEC document |
| July 12, 2022 Filed Jul 14, 2022 20:04 UTC |
COLLIS STEVEN HDirector · Chairman, President & CEO
|
Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 11,480 | $0.00 Strike: $75.61 | $0.00 |
DisclosureSEC source: 0001140859-22-000031 · wf-form4_165782904864689.xml · derivative · entry 3 COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,360 Underlying: Common Stock · 11,480 shares Expires 2023-11-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Exercisable in four equal annual installments on 11/9/17, 11/9/18, 11/9/19 and 11/9/20. Read SEC document |
| July 12, 2022 Filed Jul 14, 2022 20:04 UTC |
COLLIS STEVEN HDirector · Chairman, President & CEO
|
SaleCommon Stock | 11,480 | $142.35 | $1,634,178.00 |
DisclosureSEC source: 0001140859-22-000031 · wf-form4_165782904864689.xml · nonDerivative · entry 2 COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 205,178 F1 · shares: The sale of stock reflected in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person effective 8/20/21 and disclosed in the Company's 8-K filed with the Security and Exchange Commission on 8/26/21. Read SEC document |
| July 12, 2022 Filed Jul 14, 2022 20:04 UTC |
COLLIS STEVEN HDirector · Chairman, President & CEO
|
Exercise / conversionCommon Stock | 11,480 | $75.61 | $868,002.80 |
DisclosureSEC source: 0001140859-22-000031 · wf-form4_165782904864689.xml · nonDerivative · entry 1 COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 216,658 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale of stock reflected in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person effective 8/20/21 and disclosed in the Company's 8-K filed with the Security and Exchange Commission on 8/26/21. Read SEC document |
| July 01, 2022 Filed Jul 22, 2022 20:05 UTC |
Donato Leslie EEVP & Chief Strategy Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 1,431 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001140859-22-000036 · wf-form4_165852030995505.xml · derivative · entry 4 Donato Leslie E · CIK 0001784795 · EVP & Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,864 Underlying: Common Stock · 1,431 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Grant of restricted stock units received for no consideration that vest in three equal annual installments on July 1, 2022, July 1, 2023, and July 1, 2024. F2 · derivative.exercise_date: Grant of restricted stock units received for no consideration that vest in three equal annual installments on July 1, 2022, July 1, 2023, and July 1, 2024. F2 · derivative.expiration_date: Grant of restricted stock units received for no consideration that vest in three equal annual installments on July 1, 2022, July 1, 2023, and July 1, 2024. Read SEC document |
| July 01, 2022 Filed Jul 22, 2022 20:05 UTC |
Donato Leslie EEVP & Chief Strategy Officer
|
Tax withholdingCommon Stock | 533 | $143.14 | $76,293.62 |
DisclosureSEC source: 0001140859-22-000036 · wf-form4_165852030995505.xml · nonDerivative · entry 3 Donato Leslie E · CIK 0001784795 · EVP & Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,808.967 Read SEC document |
| July 01, 2022 Filed Jul 22, 2022 20:05 UTC |
Donato Leslie EEVP & Chief Strategy Officer
|
Exercise / conversionCommon Stock | 1,431 | $0.00 | $0.00 |
DisclosureSEC source: 0001140859-22-000036 · wf-form4_165852030995505.xml · nonDerivative · entry 2 Donato Leslie E · CIK 0001784795 · EVP & Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,341.967 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Grant of restricted stock units received for no consideration that vest in three equal annual installments on July 1, 2022, July 1, 2023, and July 1, 2024. Read SEC document |
| June 30, 2022 Filed Jul 14, 2022 20:12 UTC |
Campbell Elizabeth SExecutive Vice President
|
GrantCommon Stock | 68.603 | $120.26 | $8,250.06 |
DisclosureSEC source: 0001140859-22-000034 · wf-form4_165782953000714.xml · nonDerivative · entry 1 Campbell Elizabeth S · CIK 0001882641 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,950.87 F1 · shares: Purchase of common stock through the Employee Stock Purchase Plan exempt under Rule 16b-3(c). Read SEC document |
| June 30, 2022 Filed Jul 14, 2022 20:07 UTC |
Battaglia SilvanaExecutive Vice President
|
GrantCommon Stock | 94.46 | $120.26 | $11,359.57 |
DisclosureSEC source: 0001140859-22-000032 · wf-form4_165782921173442.xml · nonDerivative · entry 1 Battaglia Silvana · CIK 0001774724 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,371.9422 F1 · shares: Purchase of common stock through the Employee Stock Purchase Plan exempt under Rule 16b-3(c). Read SEC document |
| June 30, 2022 Filed Jul 22, 2022 20:05 UTC |
Donato Leslie EEVP & Chief Strategy Officer
|
GrantCommon Stock | 22.453 | $120.26 | $2,700.15 |
DisclosureSEC source: 0001140859-22-000036 · wf-form4_165852030995505.xml · nonDerivative · entry 1 Donato Leslie E · CIK 0001784795 · EVP & Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 910.967 F1 · shares: Purchase of common stock through the Employee Stock Purchase Plan exempt under Rule 16b-3(c). Read SEC document |
| June 14, 2022 Filed Jun 16, 2022 20:20 UTC |
COLLIS STEVEN HDirector · Chairman, President & CEO
|
Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 11,480 | $0.00 Strike: $75.61 | $0.00 |
DisclosureSEC source: 0001127602-22-017621 · form4.xml · derivative · entry 3 COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,840 Underlying: Common Stock · 11,480 shares Expires 2023-11-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Exercisable in four equal annual installments on 11/9/17, 11/9/18, 11/9/19 and 11/9/20. Read SEC document |
| June 14, 2022 Filed Jun 16, 2022 20:20 UTC |
COLLIS STEVEN HDirector · Chairman, President & CEO
|
SaleCommon Stock | 11,480 | $141.22 | $1,621,205.60 |
DisclosureSEC source: 0001127602-22-017621 · form4.xml · nonDerivative · entry 2 COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 205,178 F1 · shares: The sale of stock reflected in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person effective 8/20/21 and disclosed in the Company's 8-K filed with the Securities and Exchange Commission on 8/26/21. Read SEC document |
| June 14, 2022 Filed Jun 16, 2022 20:20 UTC |
COLLIS STEVEN HDirector · Chairman, President & CEO
|
Exercise / conversionCommon Stock | 11,480 | $75.61 | $868,002.80 |
DisclosureSEC source: 0001127602-22-017621 · form4.xml · nonDerivative · entry 1 COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 216,658 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale of stock reflected in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person effective 8/20/21 and disclosed in the Company's 8-K filed with the Securities and Exchange Commission on 8/26/21. Read SEC document |
| May 11, 2022 Filed May 13, 2022 20:59 UTC |
Walgreens Boots Alliance, Inc.10% owner
|
SaleCommon Stock | 6,000,000 | $150.00 | $900,000,000.00 |
DisclosureSEC source: 0000899243-22-018024 · doc4.xml · nonDerivative · entry 1 Walgreens Boots Alliance, Inc. · CIK 0001618921 · 10% owner Walgreens Boots Alliance Holdings LLC · CIK 0001669077 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 52,854,867 F1 · balance_after: As previously disclosed, including in the Schedule 13D filed by Walgreen Co. ("Walgreens") and others on April 15, 2014, as amended on January 16, 2015, January 25, 2016, March 22, 2016, August 25, 2016, November 4, 2016, January 6, 2021, June 3, 2021 and May 12, 2022, the Form 8-K filed by the Issuer on March 20, 2013, the Form 8-K filed by Walgreens on March 20, 2013, the Form 8-K filed by Walgreens on June 4, 2021 and the Form 8-K filed by the Issuer on June 2, 2021, the shares referenced in this Form 4 were acquired in accordance with the Framework Agreement, dated as of March 18, 2013 among Walgreens, Alliance Boots GmbH and the Issuer (the "Framework Agreement") and include 2,000,000 shares acquired pursuant to the consummation of the transactions contemplated by the Share Purchase Agreement, dated as of January 6, 2021 (the "SPA"), by and between the Reporting Person and the Issuer. F1 · ownership.direct: As previously disclosed, including in the Schedule 13D filed by Walgreen Co. ("Walgreens") and others on April 15, 2014, as amended on January 16, 2015, January 25, 2016, March 22, 2016, August 25, 2016, November 4, 2016, January 6, 2021, June 3, 2021 and May 12, 2022, the Form 8-K filed by the Issuer on March 20, 2013, the Form 8-K filed by Walgreens on March 20, 2013, the Form 8-K filed by Walgreens on June 4, 2021 and the Form 8-K filed by the Issuer on June 2, 2021, the shares referenced in this Form 4 were acquired in accordance with the Framework Agreement, dated as of March 18, 2013 among Walgreens, Alliance Boots GmbH and the Issuer (the "Framework Agreement") and include 2,000,000 shares acquired pursuant to the consummation of the transactions contemplated by the Share Purchase Agreement, dated as of January 6, 2021 (the "SPA"), by and between the Reporting Person and the Issuer. F2 · ownership.direct: These shares were held by Walgreens Boots Alliance Holdings LLC ("WBA Holdings"), an indirect wholly owned subsidiary of the Reporting Person. F3 · ownership.direct: As described in the Schedule 13D, as amended, WBA Investments, Inc., a direct wholly-owned subsidiary of the Reporting Person and the sole member of WBA Holdings, may also be deemed to beneficially own the securities reported in this Form 4. F1 · ownership.nature: As previously disclosed, including in the Schedule 13D filed by Walgreen Co. ("Walgreens") and others on April 15, 2014, as amended on January 16, 2015, January 25, 2016, March 22, 2016, August 25, 2016, November 4, 2016, January 6, 2021, June 3, 2021 and May 12, 2022, the Form 8-K filed by the Issuer on March 20, 2013, the Form 8-K filed by Walgreens on March 20, 2013, the Form 8-K filed by Walgreens on June 4, 2021 and the Form 8-K filed by the Issuer on June 2, 2021, the shares referenced in this Form 4 were acquired in accordance with the Framework Agreement, dated as of March 18, 2013 among Walgreens, Alliance Boots GmbH and the Issuer (the "Framework Agreement") and include 2,000,000 shares acquired pursuant to the consummation of the transactions contemplated by the Share Purchase Agreement, dated as of January 6, 2021 (the "SPA"), by and between the Reporting Person and the Issuer. F2 · ownership.nature: These shares were held by Walgreens Boots Alliance Holdings LLC ("WBA Holdings"), an indirect wholly owned subsidiary of the Reporting Person. F3 · ownership.nature: As described in the Schedule 13D, as amended, WBA Investments, Inc., a direct wholly-owned subsidiary of the Reporting Person and the sole member of WBA Holdings, may also be deemed to beneficially own the securities reported in this Form 4. Read SEC document |
| May 11, 2022 Filed May 13, 2022 20:04 UTC |
Krikorian LazarusSVP & Chief Accounting Officer
|
SaleCommon Stock | 4,895 | $160.00 | $783,200.00 |
DisclosureSEC source: 0001127602-22-014391 · form4.xml · nonDerivative · entry 1 Krikorian Lazarus · CIK 0001627534 · SVP & Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,079 Read SEC document |
| May 10, 2022 Filed May 12, 2022 20:44 UTC |
COLLIS STEVEN HDirector · Chairman, President & CEO
|
Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 11,480 | $0.00 Strike: $75.61 | $0.00 |
DisclosureSEC source: 0001127602-22-014278 · form4.xml · derivative · entry 3 COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,320 Underlying: Common Stock · 11,480 shares Expires 2023-11-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Exercisable in four equal annual installments on 11/9/17, 11/9/18, 11/9/19 and 11/9/20. Read SEC document |
| May 10, 2022 Filed May 12, 2022 20:44 UTC |
COLLIS STEVEN HDirector · Chairman, President & CEO
|
SaleCommon Stock | 11,480 | $159.47 | $1,830,715.60 |
DisclosureSEC source: 0001127602-22-014278 · form4.xml · nonDerivative · entry 2 COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 205,178 F1 · shares: The sale of stock reflected in this Form 4 was affected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person effective 8/20/21 and disclosed in the Company's 8-K filed with the Security and Exchange Commission on 8/26/21. Read SEC document |
| May 10, 2022 Filed May 12, 2022 20:44 UTC |
COLLIS STEVEN HDirector · Chairman, President & CEO
|
Exercise / conversionCommon Stock | 11,480 | $75.61 | $868,002.80 |
DisclosureSEC source: 0001127602-22-014278 · form4.xml · nonDerivative · entry 1 COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 216,658 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale of stock reflected in this Form 4 was affected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person effective 8/20/21 and disclosed in the Company's 8-K filed with the Security and Exchange Commission on 8/26/21. Read SEC document |
| May 10, 2022 Filed May 12, 2022 20:40 UTC |
Krikorian LazarusSVP & Chief Accounting Officer
|
Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 6,654 | $0.00 Strike: $89.58 | $0.00 |
DisclosureSEC source: 0001127602-22-014275 · form4.xml · derivative · entry 4 Krikorian Lazarus · CIK 0001627534 · SVP & Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,218 Underlying: Common Stock · 6,654 shares Expires 2025-11-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Exercisable in four equal annual installments on 11/14/19, 11/14/20, 11/14/21 and 11/14/22. F2 · balance_after: Balance reflects adjustment to previously overstated number of options. Read SEC document |
| May 10, 2022 Filed May 12, 2022 20:40 UTC |
Krikorian LazarusSVP & Chief Accounting Officer
|
SaleCommon Stock | 105 | $160.00 | $16,800.00 |
DisclosureSEC source: 0001127602-22-014275 · form4.xml · nonDerivative · entry 3 Krikorian Lazarus · CIK 0001627534 · SVP & Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,974 Read SEC document |
| May 10, 2022 Filed May 12, 2022 20:40 UTC |
Krikorian LazarusSVP & Chief Accounting Officer
|
SaleCommon Stock | 6,654 | $158.61 | $1,055,390.94 |
DisclosureSEC source: 0001127602-22-014275 · form4.xml · nonDerivative · entry 2 Krikorian Lazarus · CIK 0001627534 · SVP & Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,079 Read SEC document |
| May 10, 2022 Filed May 12, 2022 20:40 UTC |
Krikorian LazarusSVP & Chief Accounting Officer
|
Exercise / conversionCommon Stock | 6,654 | $89.58 | $596,065.32 |
DisclosureSEC source: 0001127602-22-014275 · form4.xml · nonDerivative · entry 1 Krikorian Lazarus · CIK 0001627534 · SVP & Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,733 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 02, 2022 Filed May 2, 2022 21:19 UTC |
NALLY DENNIS MDirector
|
GrantCommon Stock | 207 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-22-012866 · form4.xml · nonDerivative · entry 1 NALLY DENNIS M · CIK 0001685596 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,984 F1 · shares: Shares of common stock were issued in lieu of $31,250 quarterly cash retainer. F1 · price: Shares of common stock were issued in lieu of $31,250 quarterly cash retainer. Read SEC document |
| April 12, 2022 Filed Apr 13, 2022 20:22 UTC |
COLLIS STEVEN HDirector · Chairman, President & CEO
|
Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 11,480 | $0.00 Strike: $75.61 | $0.00 |
DisclosureSEC source: 0001127602-22-011945 · form4.xml · derivative · entry 3 COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,800 Underlying: Common Stock · 11,480 shares Expires 2023-11-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Exercisable in four equal annual installments on 11/9/17, 11/9/18, 11/9/19 and 11/9/20. Read SEC document |
| April 12, 2022 Filed Apr 13, 2022 20:22 UTC |
COLLIS STEVEN HDirector · Chairman, President & CEO
|
SaleCommon Stock | 11,480 | $162.11 | $1,861,022.80 |
DisclosureSEC source: 0001127602-22-011945 · form4.xml · nonDerivative · entry 2 COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 205,178 F1 · shares: The sale of stock reflected in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person effective 8/20/21 and disclosed in the Company's 8-K filed with the Securities and Exchange Commission on 8/26/21. Read SEC document |
| April 12, 2022 Filed Apr 13, 2022 20:22 UTC |
COLLIS STEVEN HDirector · Chairman, President & CEO
|
Exercise / conversionCommon Stock | 11,480 | $75.61 | $868,002.80 |
DisclosureSEC source: 0001127602-22-011945 · form4.xml · nonDerivative · entry 1 COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 216,658 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale of stock reflected in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person effective 8/20/21 and disclosed in the Company's 8-K filed with the Securities and Exchange Commission on 8/26/21. Read SEC document |
| March 28, 2022 Filed Mar 30, 2022 20:00 UTC |
Clark GinaExecutive Vice President
|
Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 29,520 | $0.00 Strike: $75.61 | $0.00 |
DisclosureSEC source: 0001127602-22-010646 · form4.xml · derivative · entry 3 Clark Gina · CIK 0001625811 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 29,520 shares Expires 2023-11-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Exercisable in four equal annual installments on 11/9/17, 11/9/18, 11/9/19 and 11/9/20. Read SEC document |
| March 28, 2022 Filed Mar 30, 2022 20:00 UTC |
Clark GinaExecutive Vice President
|
SaleCommon Stock | 43,704 | $153.71 | $6,717,741.84 |
DisclosureSEC source: 0001127602-22-010646 · form4.xml · nonDerivative · entry 2 Clark Gina · CIK 0001625811 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,814 F1 · shares: The sale of common stock reflected in this Form 4 was affected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person effective 2/16/2022. Read SEC document |
| March 28, 2022 Filed Mar 30, 2022 20:00 UTC |
Clark GinaExecutive Vice President
|
Exercise / conversionCommon Stock | 29,520 | $75.61 | $2,232,007.20 |
DisclosureSEC source: 0001127602-22-010646 · form4.xml · nonDerivative · entry 1 Clark Gina · CIK 0001625811 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,518 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale of common stock reflected in this Form 4 was affected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person effective 2/16/2022. Read SEC document |
| March 15, 2022 Filed Mar 16, 2022 19:59 UTC |
Battaglia SilvanaExecutive Vice President
|
SaleCommon Stock | 6,820 | $149.96 | $1,022,727.20 |
DisclosureSEC source: 0001127602-22-009474 · form4.xml · nonDerivative · entry 1 Battaglia Silvana · CIK 0001774724 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,277.4822 Read SEC document |
| March 10, 2022 Filed Mar 14, 2022 20:09 UTC |
HYLE KATHLEEN WDirector
|
GrantRestricted Stock Units · Derivative | 1,197 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-22-009100 · form4.xml · derivative · entry 1 HYLE KATHLEEN W · CIK 0001117310 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,197 Underlying: Common Stock · 1,197 shares Expires not disclosed F1 · derivative.exercise_price: Annual grant of restricted stock units received for no consideration and vests 100% on the third anniversary of the date of grant. F1 · price: Annual grant of restricted stock units received for no consideration and vests 100% on the third anniversary of the date of grant. F1 · derivative.exercise_date: Annual grant of restricted stock units received for no consideration and vests 100% on the third anniversary of the date of grant. F1 · derivative.expiration_date: Annual grant of restricted stock units received for no consideration and vests 100% on the third anniversary of the date of grant. Read SEC document |
| March 10, 2022 Filed Mar 14, 2022 20:22 UTC |
DURCAN DERMOT MARKDirector
|
GrantRestricted Stock Units · Derivative | 1,197 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0001127602-22-009129 · form4.xml · derivative · entry 1 DURCAN DERMOT MARK · CIK 0001202358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,197 Underlying: Common Stock · 1,197 shares Expires not disclosed F1 · derivative.exercise_price: Annual grant of restricted stock units received for no consideration and vests 100% on the third anniversary of the date of grant. F1 · price: Annual grant of restricted stock units received for no consideration and vests 100% on the third anniversary of the date of grant. F1 · derivative.exercise_date: Annual grant of restricted stock units received for no consideration and vests 100% on the third anniversary of the date of grant. F1 · derivative.expiration_date: Annual grant of restricted stock units received for no consideration and vests 100% on the third anniversary of the date of grant. Read SEC document |
| March 10, 2022 Filed Mar 14, 2022 20:19 UTC |
GOCHNAUER RICHARD WDirector
|
GrantRestricted Stock Units · Derivative | 1,197 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-22-009122 · form4.xml · derivative · entry 1 GOCHNAUER RICHARD W · CIK 0001214315 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,197 Underlying: Common Stock · 1,197 shares Expires not disclosed F1 · derivative.exercise_price: Annual grant of restricted stock units received for no consideration and vests 100% on the third anniversary of the date of grant. F1 · price: Annual grant of restricted stock units received for no consideration and vests 100% on the third anniversary of the date of grant. F1 · derivative.exercise_date: Annual grant of restricted stock units received for no consideration and vests 100% on the third anniversary of the date of grant. F1 · derivative.expiration_date: Annual grant of restricted stock units received for no consideration and vests 100% on the third anniversary of the date of grant. Read SEC document |
| March 10, 2022 Filed Mar 14, 2022 20:16 UTC |
GREENBERG LON RDirector
|
GrantRestricted Stock Units · Derivative | 1,197 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-22-009116 · form4.xml · derivative · entry 1 GREENBERG LON R · CIK 0001234234 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,197 Underlying: Common Stock · 1,197 shares Expires not disclosed F1 · derivative.exercise_price: Annual grant of restricted stock units received for no consideration and vests 100% on the third anniversary of the date of grant. Delivery of vested shares deferred until 1/15/2028. F1 · price: Annual grant of restricted stock units received for no consideration and vests 100% on the third anniversary of the date of grant. Delivery of vested shares deferred until 1/15/2028. F1 · derivative.exercise_date: Annual grant of restricted stock units received for no consideration and vests 100% on the third anniversary of the date of grant. Delivery of vested shares deferred until 1/15/2028. F1 · derivative.expiration_date: Annual grant of restricted stock units received for no consideration and vests 100% on the third anniversary of the date of grant. Delivery of vested shares deferred until 1/15/2028. Read SEC document |
| March 10, 2022 Filed Mar 14, 2022 20:13 UTC |
McGee Henry Wadsworth IIIDirector
|
GrantRestricted Stock Units · Derivative | 1,197 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-22-009111 · form4.xml · derivative · entry 1 McGee Henry Wadsworth III · CIK 0001307634 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,197 Underlying: Common Stock · 1,197 shares Expires not disclosed F1 · derivative.exercise_price: Annual grant of restricted stock units received for no consideration and vests 100% on the third anniversary of the date of grant. Delivery of vested shares deferred until 1/2/26. F1 · price: Annual grant of restricted stock units received for no consideration and vests 100% on the third anniversary of the date of grant. Delivery of vested shares deferred until 1/2/26. F1 · derivative.exercise_date: Annual grant of restricted stock units received for no consideration and vests 100% on the third anniversary of the date of grant. Delivery of vested shares deferred until 1/2/26. F1 · derivative.expiration_date: Annual grant of restricted stock units received for no consideration and vests 100% on the third anniversary of the date of grant. Delivery of vested shares deferred until 1/2/26. Read SEC document |
| March 10, 2022 Filed Mar 14, 2022 20:12 UTC |
HENNEY JANE E MDDirector
|
GrantRestricted Stock Units · Derivative | 1,368 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-22-009107 · form4.xml · derivative · entry 1 HENNEY JANE E MD · CIK 0001191522 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,368 Underlying: Common Stock · 1,368 shares Expires not disclosed F1 · derivative.exercise_price: Annual grant of restricted stock units received for no consideration and vests 100% on the third anniversary of the date of grant. F1 · price: Annual grant of restricted stock units received for no consideration and vests 100% on the third anniversary of the date of grant. F1 · derivative.exercise_date: Annual grant of restricted stock units received for no consideration and vests 100% on the third anniversary of the date of grant. F1 · derivative.expiration_date: Annual grant of restricted stock units received for no consideration and vests 100% on the third anniversary of the date of grant. Read SEC document |
| March 10, 2022 Filed Mar 14, 2022 20:06 UTC |
LONG MICHAEL JDirector
|
GrantRestricted Stock Units · Derivative | 1,197 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-22-009092 · form4.xml · derivative · entry 1 LONG MICHAEL J · CIK 0001186373 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,197 Underlying: Common Stock · 1,197 shares Expires not disclosed F1 · derivative.exercise_price: Annual grant of restricted stock units received for no consideration and vests 100% on the third anniversary of the date of grant. F1 · price: Annual grant of restricted stock units received for no consideration and vests 100% on the third anniversary of the date of grant. F1 · derivative.exercise_date: Annual grant of restricted stock units received for no consideration and vests 100% on the third anniversary of the date of grant. F1 · derivative.expiration_date: Annual grant of restricted stock units received for no consideration and vests 100% on the third anniversary of the date of grant. Read SEC document |
| March 10, 2022 Filed Mar 14, 2022 20:04 UTC |
NALLY DENNIS MDirector
|
GrantRestricted Stock Units · Derivative | 1,197 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-22-009086 · form4.xml · derivative · entry 1 NALLY DENNIS M · CIK 0001685596 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,197 Underlying: Common Stock · 1,197 shares Expires not disclosed F1 · derivative.exercise_price: Annual grant of restricted stock units received for no consideration and vests 100% on the third anniversary of the date of the grant. F1 · price: Annual grant of restricted stock units received for no consideration and vests 100% on the third anniversary of the date of the grant. F1 · derivative.exercise_date: Annual grant of restricted stock units received for no consideration and vests 100% on the third anniversary of the date of the grant. F1 · derivative.expiration_date: Annual grant of restricted stock units received for no consideration and vests 100% on the third anniversary of the date of the grant. Read SEC document |
| March 09, 2022 Filed Mar 11, 2022 20:41 UTC |
Battaglia SilvanaExecutive Vice President
|
Exercise / conversionRestricted Stock Units · Derivative | 1,211 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-22-008997 · form4.xml · derivative · entry 3 Battaglia Silvana · CIK 0001774724 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,422 Underlying: Common Stock · 1,211 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Grant of restricted stock units received for no consideration that vest in three equal annual installments on March 9, 2022, March 9, 2023, and March 9, 2024. F1 · price: Grant of restricted stock units received for no consideration that vest in three equal annual installments on March 9, 2022, March 9, 2023, and March 9, 2024. F1 · derivative.exercise_date: Grant of restricted stock units received for no consideration that vest in three equal annual installments on March 9, 2022, March 9, 2023, and March 9, 2024. F1 · derivative.expiration_date: Grant of restricted stock units received for no consideration that vest in three equal annual installments on March 9, 2022, March 9, 2023, and March 9, 2024. Read SEC document |
| March 09, 2022 Filed Mar 11, 2022 20:41 UTC |
Battaglia SilvanaExecutive Vice President
|
Tax withholdingCommon Stock | 537 | $145.83 | $78,310.71 |
DisclosureSEC source: 0001127602-22-008997 · form4.xml · nonDerivative · entry 2 Battaglia Silvana · CIK 0001774724 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,097.4822 Read SEC document |
| March 09, 2022 Filed Mar 11, 2022 20:41 UTC |
Battaglia SilvanaExecutive Vice President
|
Exercise / conversionCommon Stock | 1,211 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-22-008997 · form4.xml · nonDerivative · entry 1 Battaglia Silvana · CIK 0001774724 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,634.4822 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Grant of restricted stock units received for no consideration that vest in three equal annual installments on March 9, 2022, March 9, 2023, and March 9, 2024. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.